Abstract Purpose of Review Multiple guidelines and recommendations have been written to
address the perioperative management of antiplatelet and anticoagulant drugs. In this …

Although most physicians are comfortable managing the limited anticoagulant effect of
aspirin, the recent administration of potent P2Y 12 receptor inhibitors in patients undergoing …

Up to 11% of patients presenting with acute coronary syndromes undergo coronary artery
bypass grafting. Guidelines largely recommend a one-size-fits-all preoperative …

With the ever‐increasing number of patients on anticoagulant or antiplatelet medications
presenting for a dermatological surgical procedure, dermatological surgeons are facing the …

Based on variable pharmacodynamic responsiveness and platelet reactivity recovery after
discontinuation of P2Y12 receptor inhibitors, preoperative platelet function testing may …

Background Up to 15% of patients require coronary artery bypass grafting (CABG) during
dual antiplatelet therapy. Available evidence suggests an association between platelet …

Background Dual antiplatelet therapy is recommended for patients with acute coronary
syndromes (ACS). Approximately 10% to 15% of these patients will undergo coronary artery …

Nearly 20% of patients will need non-cardiac surgery within 1 year of coronary stenting and
their management is complicated by concomitant antiplatelet therapy. Platelet function …

OBJECTIVES We tested the possible value of routine aggregometry testing for bleeding
prediction following coronary artery bypass grafting in patients who received preoperative …

We carried out a literature search in MEDLINE (PubMed) and EMBASE literature databases
to provide a concise review of the role of viscoelastic testing in assessing peri-interventional …